The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.
about
Polymeric drug delivery for the treatment of glioblastomaIn vitro drug response and efflux transporters associated with drug resistance in pediatric high grade glioma and diffuse intrinsic pontine gliomaPostradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?Central nervous system cancersThe future of high-grade glioma: Where we are and where are we going.Nanotechnology-novel therapeutics for CNS disordersSilicon micro- and nanofabrication for medicineWhy dapsone stops seizures and may stop neutrophils' delivery of VEGF to glioblastoma.Contribution of case reports to glioblastoma research: systematic review and analysis of pattern of citation.Annexin 2A sustains glioblastoma cell dissemination and proliferation.Survival outcomes and safety of carmustine wafers in the treatment of high-grade gliomas: a meta-analysis.Phenotypic and functional characterization of Glioblastoma cancer stem cells identified through 5-aminolevulinic acid-assisted surgery [corrected].Evaluation of post-operative complications associated with repeat resection and BCNU wafer implantation in recurrent glioblastoma.Markers of cell division cycle in glioblastoma: significance in prediction of treatment response and patient prognosis.Safety and efficacy of Gliadel wafers for newly diagnosed and recurrent glioblastomas.
P2860
Q27010046-4FDBC413-2279-4822-B95C-B486FEA00203Q28487205-14816D0B-493C-472C-B81F-EEA1D2D1E2B1Q30418915-4580D859-7A5E-4027-9836-B8A5C2A85D2FQ34014740-F89467AC-A0AE-4E4B-A464-9C4684AF8C67Q35114090-FD597445-5EB1-41D5-A389-F5BDEDDA1961Q37173643-277D51E5-D4B6-4273-A84D-D90CC4D1858DQ37184228-4025AC6C-E597-4AAB-A49E-635F87216214Q38007011-89C235E5-071A-458D-B51E-0D461D145E8DQ38017692-E2CE22F6-6BFF-46CE-8979-C3E5CEAA53EDQ38840667-F8E8C65D-FC99-49E6-B4F8-3F859334BC73Q39046974-163B7522-5990-4D7C-9B0D-0111BE5D4632Q44737792-AA17F9A9-CC93-4F73-9D81-4EFAA07A45D8Q45983482-39FCBD3F-F8EE-4FB9-8B0E-A2A5895F2A41Q48131838-155EB001-C547-442D-8E6A-155B99473398Q48465986-70B9B051-5C65-441F-9CBA-00C9B5CB06A8
P2860
The sequential use of carmustine wafers (Gliadel®) and post-operative radiotherapy with concomitant temozolomide followed by adjuvant temozolomide: a clinical review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The sequential use of carmusti ...... mozolomide: a clinical review.
@en
The sequential use of carmustine wafers
@nl
type
label
The sequential use of carmusti ...... mozolomide: a clinical review.
@en
The sequential use of carmustine wafers
@nl
prefLabel
The sequential use of carmusti ...... mozolomide: a clinical review.
@en
The sequential use of carmustine wafers
@nl
P2093
P2860
P1476
The sequential use of carmusti ...... emozolomide: a clinical review
@en
P2093
Sanjay Dixit
Shailendra Achawal
P2860
P304
P356
10.3109/02688697.2010.550342
P577
2011-02-23T00:00:00Z